EntrepreneurialCheck
John Waldeisen estimated net worth profile

John Waldeisen Net Worth (Estimated)

CEO at Lucira Health · YC W15

est. wealth $75.0M

Quick answer

John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026.

John Waldeisen is CEO at Lucira Health (YC W15). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameJohn Waldeisen
RoleCEO
CompanyLucira Health
YC batchW15
Est. company val$2.0B
Assumed ownership4%
Est. paper wealth / net worth$75.0M
$52.5M – $112.5M
  • Company status: Public
  • Education: B.S. Engineering Science, Penn State (2007); Ph.D. Bioengineering, University of California, Berkeley
  • Region: United States of America
  • Industries: Healthcare, Diagnostics
  • Team size: 43
  • Website: https://www.lucirahealth.com/

Who is John Waldeisen?

John Waldeisen is a co-founder of Lucira Health (originally Diassess), a company that developed the first FDA-approved at-home COVID-19 test. He holds a bachelor's degree in engineering science from Penn State and a doctoral degree in bioengineering from the University of...

Highlights:

  • B.S. Engineering Science, Penn State (2007)
  • Ph.D. Bioengineering, University of California, Berkeley
  • Co-founded Lucira Health, which joined Y-Combinator in 2015 and received FDA app

About Lucira Health

Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in...

Model inputs

FAQ: John Waldeisen net worth and Lucira Health valuation

What is John Waldeisen's net worth?

John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.

John Waldeisen net worth

John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026. This John Waldeisen net worth figure is estimated paper wealth, not a verified statement of assets.

How much is John Waldeisen worth?

John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026. How much John Waldeisen is worth here means estimated paper wealth from public company and role data — not financial advice.

How rich is John Waldeisen?

John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026. “How rich is John Waldeisen” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.

John Waldeisen fortune

John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026. This John Waldeisen fortune figure is estimated paper wealth only, not a verified statement of assets.

John Waldeisen equity value

John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026. John Waldeisen equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.

What is Lucira Health valuation?

Lucira Health's estimated valuation on Entrepreneurial Check is $2.0B. Independent model output, not a verified appraisal or official mark.

What is Lucira Health post-money valuation?

Lucira Health's estimated valuation on Entrepreneurial Check is $2.0B. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.

What is Lucira Health CEO net worth?

John Waldeisen is listed as CEO at Lucira Health. John Waldeisen's estimated net worth / paper wealth is $75.0M (range $52.5M–$112.5M) as of 2026. This Lucira Health CEO net worth figure is an independent paper-wealth estimate, not verified net worth.

What is Lucira Health funding?

Lucira Health funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Lucira Health raised is not a complete cap table — figures are estimates only.

How much did Lucira Health raise?

How much Lucira Health raised, when disclosed, informs the estimated Lucira Health valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.

How much money did Lucira Health raise?

How much money Lucira Health raised, when a public figure is available, is a model input for the estimated Lucira Health valuation on this profile. Estimates only — not a complete cap table.

What is Lucira Health series funding?

Lucira Health series funding, when a public raise is disclosed, informs the estimated Lucira Health valuation here. Not a complete financing history.

What company is John Waldeisen building?

John Waldeisen is CEO at Lucira Health, a Y Combinator-backed startup (batch W15).

What does Lucira Health do?

Lucira Health — Next generation infectious disease test kits

What YC batch is John Waldeisen from?

John Waldeisen is associated with Y Combinator batch W15.

Where did John Waldeisen go to school?

Public profiles associate John Waldeisen with B.S. Engineering Science, Penn State (2007); Ph.D. Bioengineering, University of California, Berkeley.

What other companies is John Waldeisen connected to?

Public associations for John Waldeisen include Diassess Inc., Lucira Health.

Where is John Waldeisen based?

Public directory data lists John Waldeisen's region as United States of America.

What industry is John Waldeisen in?

John Waldeisen is listed under Healthcare, Diagnostics.

How big is Lucira Health?

Public data lists Lucira Health's team size as 43.

What is Lucira Health's status?

Lucira Health is listed as Public in public company data.

What else is notable about John Waldeisen?

B.S. Engineering Science, Penn State (2007).

Is Entrepreneurial Check affiliated with Y Combinator?

No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.